ArticleBMJ open2021

Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare.

Siew Eng Choon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.